Literature DB >> 3896100

Cholecystokinin-mediated synaptic function and the treatment of neuropsychiatric disease.

T N Chase, P Barone, G Bruno, S L Cohen, J Juncos, M Knight, S Ruggeri, L Steardo, C A Tamminga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3896100     DOI： 10.1111/j.1749-6632.1985.tb29948.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  2 in total

1.  Neuronal cholecystokinin and schizophrenia: pathogenic and therapeutic studies.

Authors:  C A Tamminga; R L Littman; L D Alphs; T N Chase; G K Thaker; A M Wagman
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophrenia.

Authors:  E Peselow; B Angrist; A Sudilovsky; J Corwin; J Siekierski; F Trent; J Rotrosen
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.